Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)

CNY 42.07

(-0.45%)

Market Cap (In CNY)

6.45 Billion

Revenue (In CNY)

4.18 Billion

Net Income (In CNY)

521.45 Million

Avg. Volume

1.76 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
39.82-71.38
PE
-
EPS
-
Beta Value
0.716
ISIN
CNE000001HB7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jun Wang
Employee Count
-
Website
https://www.whjm.com
Ipo Date
2004-04-19
Details
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.